STOCK TITAN

Align Technology Inc - ALGN STOCK NEWS

Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.

Align Technology, Inc. (ALGN) is a global leader in digital orthodontic solutions, pioneering innovations like Invisalign clear aligners and iTero intraoral scanners. This page provides official updates on corporate developments, financial performance, and advancements in digital dentistry.

Access real-time press releases, earnings reports, and strategic announcements directly from the company. Investors will find quarterly results and regulatory filings, while industry professionals can track product launches, clinical studies, and partnership agreements.

Our curated collection includes updates on:
• Financial disclosures (earnings, SEC filings)
• Product innovations (new aligner technologies, scanner enhancements)
• Strategic initiatives (global expansions, research collaborations)
• Industry recognition (awards, clinical study results)

Bookmark this page for streamlined access to ALGN's latest developments. Verify investment hypotheses or stay informed about advancements in clear aligner therapy through primary-source updates.

Rhea-AI Summary

Align Technology has initiated an accelerated stock repurchase (ASR) agreement with Goldman Sachs to buy back $100 million of its common stock, part of a larger $600 million repurchase program announced in 2018. The ASR will lead to an initial delivery of approximately 134,300 shares, with the final amount determined by the stock's average price during the buyback period. Completion of the ASR is expected by August 2021. Align holds around $1.1 billion in cash and equivalents, which will fund this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
buyback
-
Rhea-AI Summary

Align Technology, Inc. reported a record Q1 2021 revenue of $894.8 million, up 62.4% year-over-year, with diluted EPS at $2.51. Clear Aligner revenues reached $753.3 million, a 56.4% increase compared to the prior year. Operating income soared 222.4% to $225.4 million, resulting in a 25.2% operating margin. Cash reserves totaled $1.1 billion. The company celebrated treating over 10 million Invisalign patients, showcasing significant growth, especially among teenagers. Align's future outlook anticipates net revenues between $3.7 billion and $3.9 billion for 2021, reflecting continued momentum.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
-
Rhea-AI Summary

Align Technology has extended its multi-year agreement with DECA Dental Group for the Invisalign system through early 2025. This partnership will enhance DECA-affiliated practices' access to Align’s iTero Element 5D imaging systems, which support digital workflows in dentistry. The iTero Element 5D can capture 3D impressions and Near Infrared Images without harmful radiation. Align, a leader in orthodontics, aims to improve patient experiences and outcomes through its digital platform and technologies. This collaboration underscores Align's commitment to innovation in dental care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
none
-
Rhea-AI Summary

Align Technology plans to open its first aligner manufacturing facility in the EMEA region, specifically in Wroclaw, Poland, set to start operations in early 2022. This facility will enhance customer support for over 62,700 trained doctors by improving turnaround and delivery times. The investment aims to address a large market opportunity with over 5 million annual orthodontic case starts in the EMEA region. The new site will create more than 2,500 jobs and is part of Align's strategy to solidify its presence in the region and cater to the growing demand for its Invisalign system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary

Align Technology announced support for expanding vaccination access through U.S. dentists. As vaccination efforts ramp up, the company highlights the role of dentists, who already serve 31 million Americans annually, in administering vaccines. Federal policies have enabled dentists to provide COVID-19 vaccinations, suggesting a broader role for dentists in public health. Align emphasizes that utilizing trusted community providers can enhance future vaccination initiatives. This strategy could integrate dentists into routine immunizations, improving public health outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
none
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) will report its Q1 2021 financial results on April 28, 2021, post-market close. The financial results will be available at 4:00 p.m. ET on the Company’s Investor Relations website. A conference call will follow at 4:30 p.m. ET to discuss these results, accessible through a dedicated audio webcast. A replay of the call will be available for one month post-event, allowing stakeholders to review the details at their convenience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) has partnered with U.S. Ski & Snowboard, designating the Invisalign brand as the Official Smile of the organization. This multi-year sponsorship will include original content for social media and the U.S. Ski & Snowboard website. Athletes will join the Invisalign Smile Squad, receiving treatment and sharing their experiences online. Notable athletes include Olympic champions Jamie Anderson, Maddie Mastro, Red Gerard, and David Wise, who express enthusiasm for enhancing their smiles through Invisalign.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.31%
Tags
none
-
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) reported a favorable arbitration outcome, receiving a total of $99.7 million from SDC Entities. This includes a $54.2 million payment already made. The arbitration mandates SDC to pay an additional $45.5 million plus interest of $3,000 per day starting March 13, 2021. CFO John Morici highlighted strong performance in the first quarter, driven by increasing demand for Invisalign Clear Aligners and iTero Systems. Despite this positive momentum, the company remains cautious about potential risks, including market competition and economic conditions affecting consumer behavior.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.18%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.08%
Tags
none
Align Technology Inc

Nasdaq:ALGN

ALGN Rankings

ALGN Stock Data

12.55B
68.38M
6.67%
91.19%
5.13%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
TEMPE